Patent details

EP3615541 Title: POLYMORPHS AND SOLID FORMS OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMIDE, AND METHODS OF PRODUCTION

Basic Information

Publication number:
EP3615541
PCT Application Number:
EP2018060820
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP187285143
PCT Publication Number:
WO2018197653
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPHS AND SOLID FORMS OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMIDE, AND METHODS OF PRODUCTION
French Title of Invention:
POLYMORPHES, FORMES SOLIDES DE (S)-2-((2-((S)-4-(DIFLUOROMÉTHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZÉPIN-9-YL)AMINO)PROPANAMIDE, ET PROCÉDÉS DE PRODUCTION
German Title of Invention:
POLYMORPHE UND FESTE FORMEN VON (S)-2-((2-((S)-4-(DIFLUORMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMID UND VERFAHREN ZUR HERSTELLUNG
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
08/04/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
15/04/2025
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
19/03/2025
Unitary Effect Registration Date:
15/04/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
26/04/2018
Grant date:
19/03/2025
EP Publication Date:
04/03/2020
PCT Publication Date:
01/11/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/03/2025
EP B1 Publication Date:
19/03/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/04/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/03/2025
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
SAVAGE, Scott
Address:
United States (US)

2

Name:
CHAKRAVARTY, Paroma
Address:
United States (US)

3

Name:
NAGAPUDI, Karthik
Address:
United States (US)

4

Name:
KELLY, Sean M.
Address:
United States (US)

5

Name:
HAN, Chong
Address:
United States (US)

Priority

Priority Number:
201762491812 P
Priority Date:
28/04/2017
Priority Country:
United States (US)

Classification

IPC classification:
C07D 498/04; A61K 31/553; C07B 63/00; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202512
Publication date:
19/03/2025
Description:
Grant (B1)

2

Issue number:
202513
Publication date:
26/03/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202520
Publication date:
14/05/2025
Description:
Unitary Effect Request Receipt

4

Issue number:
202520
Publication date:
14/05/2025
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages